SEC Form 4 · accession 0001209191-15-082524
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
K Peony Yu
Officer — VP, Clinical Development
Period of report
Nov 25, 2015
Accepted (ET)
Nov 30, 2015 · 7:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 25, 2015 | S | 344 | $30.00 | D | 183,001 | D | |
| Common StockF1 | Nov 30, 2015 | S | 4,656 | $30.00 | D | 178,345 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.